Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-03-23
DOI
10.3389/fimmu.2017.00321
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Osteopontin in Neurodegenerative Diseases
- (2018) Miryam Carecchio et al. JOURNAL OF ALZHEIMERS DISEASE
- Therapeutic strategies targeting B-cells in multiple sclerosis
- (2016) Ron Milo AUTOIMMUNITY REVIEWS
- Thrombin Cleavage of Osteopontin Modulates Its Activities in Human CellsIn Vitroand Mouse Experimental Autoimmune EncephalomyelitisIn Vivo
- (2016) Elena Boggio et al. Journal of Immunology Research
- ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
- (2015) Robert C. Sergott et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis
- (2014) G. Murugaiyan et al. JOURNAL OF IMMUNOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
- (2014) Violaine K. Harris et al. Molecular Diagnosis & Therapy
- No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis
- (2014) Tessel F Runia et al. Multiple Sclerosis Journal
- Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis
- (2014) Giuseppe Cappellano et al. VACCINE
- N-Terminal Rather Than Full-Length Osteopontin or Its C-Terminal Fragment Is Associated With Carotid-Plaque Inflammation in Hypertensive Patients
- (2013) T. Wolak et al. AMERICAN JOURNAL OF HYPERTENSION
- CD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis
- (2013) Kelly M. Flynn et al. AMERICAN JOURNAL OF PATHOLOGY
- The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis
- (2013) Pietro Iaffaldano et al. BRAIN BEHAVIOR AND IMMUNITY
- CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells
- (2013) Lizette Ghazi-Visser et al. FASEB JOURNAL
- Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica
- (2013) Yuko Shimizu et al. JOURNAL OF NEUROIMMUNOLOGY
- Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development
- (2013) Pia Kivisäkk et al. Multiple Sclerosis Journal
- Overexpression of CD44 in Neural Precursor Cells Improves Trans- Endothelial Migration and Facilitates Their Invasion of Perivascular Tissues In Vivo
- (2013) Cyrille Deboux et al. PLoS One
- The role of T cell apoptosis in nervous system autoimmunity
- (2012) C. Comi et al. AUTOIMMUNITY REVIEWS
- The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression
- (2012) Cristoforo Comi et al. Clinical & Developmental Immunology
- Hyaluronan Anchored to Activated CD44 on Central Nervous System Vascular Endothelial Cells Promotes Lymphocyte Extravasation in Experimental Autoimmune Encephalomyelitis
- (2012) Clayton W. Winkler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immune-mediated CNS diseases: A review on nosological classification and clinical features
- (2011) Uwe K. Zettl et al. AUTOIMMUNITY REVIEWS
- CD44 Reciprocally Regulates the Differentiation of Encephalitogenic Th1/Th17 and Th2/Regulatory T Cells through Epigenetic Modulation Involving DNA Methylation of Cytokine Gene Promoters, Thereby Controlling the Development of Experimental Autoimmune Encephalomyelitis
- (2011) H. Guan et al. JOURNAL OF IMMUNOLOGY
- Treatment of collagen‐induced arthritis with an anti‐osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells
- (2008) Kexing Fan et al. ARTHRITIS AND RHEUMATISM
- Osteopontin: Role in immune regulation and stress responses
- (2008) Kathryn X. Wang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis
- (2008) Ivan Nestorov et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study
- (2008) MA Leone et al. Multiple Sclerosis Journal
- Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor‐kappa B ligand, and high‐sensitivity C‐reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate
- (2008) H. P. Sennels et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started